Evaluation of FASTinov Ultrarapid Flow Cytometry Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures-Reference-Cited by-同舟云学术

Evaluation of FASTinov Ultrarapid Flow Cytometry Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures

Published:2021-09-20 Issue:10 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Silva-Dias Ana¹²^ORCID,Pérez-Viso Blanca³,Martins-Oliveira Inês¹,Gomes Rosário¹,Rodrigues Acácio G.¹²⁴⁵,Cantón Rafael³^ORCID,Pina-Vaz Cidália¹²⁴^ORCID

Affiliation:

1. FASTinov, S.A., Matosinhos, Portugal

2. CINTESIS—Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal

3. Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain

4. Division of Microbiology, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal

5. Department of Emergency and Intensive Care, Centro Hospitalar Sao Joao, Porto, Portugal

Abstract

The FASTinov flow cytometry kit, an ultrarapid antimicrobial susceptibility test, was directly evaluated on positive blood cultures (BC) at two sites: (i) FASTinov, S.A., in Porto, Portugal, using BC spiked with well-characterized bacteria, and (ii) Ramon y Cajal University Hospital in Madrid, Spain, using positive BC from patients. Two kits were evaluated, FAST gramneg ( Enterobacterales , Pseudomonas , Acinetobacter ) and FAST grampos ( Staphylococcus , Enterococcus ).

Funder

EC | Employment, Social Affairs & Inclusion | European Social Fund

H2020 Fast Track to Innovation

MEC | Fundação para a Ciência e a Tecnologia

MEC | Instituto de Salud Carlos III

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00544-21

Reference27 articles.

1. The STOP-AB trial protocol: efficacy and safety of discontinuing patient antibiotic treatment when physicians no longer consider it necessary

2. European Medicines Agency, European Centre for Disease Prevention and Control. 2009. The bacterial challenge: time to react, p 32. European Centre for Disease Prevention and Control, Stockholm, Sweden.

3. Potential Impact of Flow Cytometry Antimicrobial Susceptibility Testing on the Clinical Management of Gram-Negative Bacteremia Using the FASTinov® Kit

4. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles

5. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis;Microorganisms;2024-09-03

2. Evaluation of Vitek-2 and MicroScan ASTs directly from positive blood culture: A cost-effective 24-h reduction for Enterobacterales and staphylococci;Journal of Microbiological Methods;2024-09

3. Rapid Phenotypic and Genotypic Antimicrobial Susceptibility Testing Approaches for Use in the Clinical Laboratory;Antibiotics;2024-08-22

4. Blood culture-free ultra-rapid antimicrobial susceptibility testing;Nature;2024-07-24

5. Performance of Flow Cytometry-Based Rapid Assay in Detection of Carbapenemase-Producing Enterobacterales;International Journal of Molecular Sciences;2024-07-18